Search results
Start date:
Mar 04, 2025
End date:
Mar 05, 2025
Obesity at the Limits 2025 is a new major event running five international meetings across the globe on March 4th to March 5th 2025, coinciding with World Obesity Day. The event will include a range of live speakers and streamed presentations from select global experts meeting from Europe, Africa / the Middle East, Asia Pacific, North America, and South America.
View more
Added:
6 months ago
Source:
Radcliffe CVRM
A new study has found that orforglipron, a novel, once-daily oral glucagon-like peptide-1 (GLP-1) receptor agonist, leads to significant weight loss in adults with obesity or overweight and type 2 diabetes (T2D). The findings come from the phase 3 ATTAIN-2 trial.¹Orforglipron is a non-peptide, small-molecule GLP-1 receptor agonist, distinguishing it from existing injectable peptide-based…
View more
Added:
10 months ago
Source:
Radcliffe CVRM
A secondary analysis of the SUMMIT trial has found that the benefits of tirzepatide on reducing the risk of cardiovascular death or worsening heart failure (HF) are consistent across all levels of obesity in patients with heart failure with preserved ejection fraction (HFpEF).¹ However, patients with a higher baseline body mass index (BMI) experienced greater improvements in exercise capacity and…
View more
Added:
1 year ago
ECO 2025 - Three-year findings of tirzepatide treatment, a GIP/GLP-1 agonist, for patients with prediabetes observed stable weight loss results and suggests that tirzepatide is a viable option for patients with indication. The study also observed the total weight loss patients may obtain can be predicted within the first month of treatment with tirzepatide.Prof Luca Busetto (Padova University…
View more
Metabolic Surgery Superior to GLP-1 RAs for Long-Term Outcomes in Patients with Diabetes and Obesity
Added:
8 months ago
Source:
Radcliffe CVRM
News
Start date:
Mar 07, 2025
End date:
Mar 07, 2025
Obesity & Weight Management Alliance Conference 2025 will take place on March 7th 2025 in London at Thistle London Marble Arch.
View more
Start date:
Feb 01, 2025
End date:
Feb 02, 2025
ICDOMD - 2025 will take place from February 1st to February 2nd 2025 in Geneva at Bernina Hotel Geneva.
View more
Added:
1 year ago
In this third session of Advancements in Obesity Management (AOM) 2024, the panel explore the biological,environmental,psychologicaland social factors contributing to obesity.
View more
Added:
1 year ago
In the final session of Advancements in Obesity Management (AOM) 2024, the panel discuss practical considerations in utilising new pharmacological therapies for treating obesity and cover the extensive development pipeline. The current understanding of clinical outcome data and patient referral criteria are also discussed for surgical approaches.
View more
Angela Fitch
Research Area(s) / Expertise:
Job title: Chief Medical Officer and Co-Founder of knownwell
Author